SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-20-011373
Filing Date
2020-05-29
Accepted
2020-05-29 18:32:09
Documents
1
Period of Report
2020-05-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3202
  Complete submission text file 0001567619-20-011373.txt   4507
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Issuer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALLERGAN 2525 DUPONT DRIVE IRVINE CA 92612
Business Address
PYOTT DAVID E I (Reporting) CIK: 0001051578 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26727 | Film No.: 20930203